ADRB2 and gastrointestinal disease: As a result of these protective or promotive effects, classic neurotransmitter related drugs, such as β-AR antagonists, serotonin receptor antagonists, AChR antagonists and DA receptors agonists, may have clinical significance in the treatment of gastrointestinal diseases and are expected to become candidates for combined drug therapy.